Heron Therapeutics (HRTX) Expected to Announce Earnings on Thursday

Heron Therapeutics (NASDAQ:HRTX) is expected to be posting its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Heron Therapeutics to post earnings of ($0.03) per share and revenue of $37.37 million for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Heron Therapeutics Price Performance

HRTX opened at $1.77 on Tuesday. Heron Therapeutics has a 12 month low of $1.04 and a 12 month high of $3.93. The stock has a market cap of $269.21 million, a P/E ratio of -9.83 and a beta of 1.60. The stock’s 50 day moving average price is $1.66 and its 200 day moving average price is $1.71.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Needham & Company LLC reiterated a “buy” rating and set a $4.00 price target on shares of Heron Therapeutics in a research report on Wednesday, December 4th. StockNews.com cut Heron Therapeutics from a “buy” rating to a “hold” rating in a research report on Wednesday, January 29th.

About Heron Therapeutics

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.